Ibere Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ibere Pharmaceuticals's balance sheet done over the years? Its assets were worth $138,710,328 last year, which is more than in the previous period. 8% of Ibere Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $11,539,344, which means an increase by 1656% compared compared to last year.

Debt to Assets

Ibere Pharmaceuticals (NYSE:IBER): Debt to assets
2020 676366 657.12K 97.16%
2021 138710328 11.53M 8.32%

IBER Balance Sheet (2020 – 2021)

2021 2020
Assets
Current assets:
Cash and cash equivalents
458.38K175.36K
Short term investments
00
Net receivables
00
Inventory
00
Other current assets
235K0
Total current assets
693.38K175.36K
Non-current assets:
Property, Plant and Equipment
00
Goodwill
00
Intangible assets
00
Long term investments
00
Other non-current assets
138.01M0
Total non-current assets
138.01M501K
Total assets
138.71M676.36K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00
Short term debt
0169K
Total current liabilities
372.44K657.12K
Non-current liabilities:
Long term debt
00
Deferred tax
00
Other non-current liabilities
11.16M0
Total non-current liabilities
11.16M0
Total liabilities
11.53M657.12K
Data source